Advanced search
Publication Cover
Expert Opinion on Drug Discovery Volume 12, 2017 - Issue 4
Submit an article Journal homepage
853
Views
40
CrossRef citations to date
0
Altmetric
Review

Signaling bias in drug discovery

Terry KenakinDepartment of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, NC, USACorrespondence[email protected]
View further author information
Pages 321-333 | Received 11 Nov 2016, Accepted 16 Feb 2017, Published online: 09 Mar 2017

Citations (40)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ximene Antunes, Leandro Kasuki & Mônica R. Gadelha. (2021) New and emerging pharmacological treatment options for acromegaly. Expert Opinion on Pharmacotherapy 22:12, pages 1615-1623.
Read now

Articles from other publishers (39)

Daniel Wirth, Ece Özdemir & Kalina Hristova. (2023) Quantification of ligand and mutation-induced bias in EGFR phosphorylation in direct response to ligand binding. Nature Communications 14:1.
Crossref
Kelly Karl, Sudarshan Rajagopal & Kalina Hristova. (2023) Quantitative assessment of ligand BIAS from BIAS plots: The BIAS coefficient “kappa”. Biochimica et Biophysica Acta (BBA) - General Subjects, pages 130428.
Crossref
Vinay Kumar Sharma, Kiersten Campbell, Xuyu Yang, Ryan Dale & Y. Peng Loh. (2023) Characterization of serotonin‐5‐HTR1E signaling pathways and its role in cell survival . The FASEB Journal 37:5.
Crossref
Elmer Zapata-Mercado, Gabriel Biener, Daniel M. McKenzie, William C. Wimley, Elena B. Pasquale, Valerica Raicu & Kalina Hristova. (2022) The efficacy of receptor tyrosine kinase EphA2 autophosphorylation increases with EphA2 oligomer size. Journal of Biological Chemistry 298:10, pages 102370.
Crossref
Bianca Plouffe, Angeliki Karamitri, Tilman Flock, Jonathan M. Gallion, Shane HoustonCarole A. DalyAmélie Bonnefond, Jean-Luc Guillaume, Christian Le Gouill, Phillipe Froguel, Olivier Lichtarge, Xavier Deupi, Ralf Jockers & Michel Bouvier. (2022) Structural Elements Directing G Proteins and β-Arrestin Interactions with the Human Melatonin Type 2 Receptor Revealed by Natural Variants. ACS Pharmacology & Translational Science 5:2, pages 89-101.
Crossref
Delma Maria Cunha, Pedro Cunha Tzirulnik, Patricia Cristina dos Santos Costa, Danton Machado Cunha & Ademir Batista da Cunha. (2022) Association of Anti-β1 and Anti-M2 Antibodies with Autonomic Nervous System Modulation in Patients with Chronic Chagas Cardiomyopathy. International Journal of Cardiovascular Sciences.
Crossref
Nick D. Bergkamp, Marco Siderius & Martine J. Smit. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology 163 190 .
Fozia Ahmed, Elmer Zapata-Mercado, Sanim Rahman & Kalina Hristova. (2021) The Biased Ligands NGF and NT-3 Differentially Stabilize Trk-A Dimers. Biophysical Journal 120:1, pages 55-63.
Crossref
A. Nieto, T. Bailey, K. Kaczanowska & P. McDonald. 2022. Behavioral Neurobiology of GABAB Receptor Function. Behavioral Neurobiology of GABAB Receptor Function 81 118 .
Fozia AhmedMichael D. PaulKalina Hristova. (2020) The biophysical basis of receptor tyrosine kinase ligand functional selectivity: Trk-B case study. Biochemical Journal 477:23, pages 4515-4526.
Crossref
Kelly Karl, Michael D. Paul, Elena B. Pasquale & Kalina Hristova. (2020) Ligand bias in receptor tyrosine kinase signaling. Journal of Biological Chemistry 295:52, pages 18494-18507.
Crossref
Damien Jullié, Arisbel B. Gondin, Mark von Zastrow & Meritxell Canals. (2020) Opioid Pharmacology under the Microscope. Molecular Pharmacology 98:4, pages 425-432.
Crossref
Alexander Gillis, Varun Sreenivasan & Macdonald J. Christie. (2020) Intrinsic Efficacy of Opioid Ligands and Its Importance for Apparent Bias, Operational Analysis, and Therapeutic Window. Molecular Pharmacology 98:4, pages 410-424.
Crossref
Viktoriya Lukasheva, Dominic Devost, Christian Le Gouill, Yoon Namkung, Ryan D. Martin, Jean-Michel Longpré, Mohammad Amraei, Yuji Shinjo, Mireille Hogue, Monique Lagacé, Billy Breton, Junken Aoki, Jason C. Tanny, Stéphane A. Laporte, Graciela Pineyro, Asuka Inoue, Michel Bouvier & Terence E. Hébert. (2020) Signal profiling of the β1AR reveals coupling to novel signalling pathways and distinct phenotypic responses mediated by β1AR and β2AR. Scientific Reports 10:1.
Crossref
Pakhuri Mehta, Przemysław Miszta, Przemysław Rzodkiewicz, Olga Michalak, Piotr Krzeczyński & Sławomir Filipek. (2020) Enigmatic Histamine Receptor H4 for Potential Treatment of Multiple Inflammatory, Autoimmune, and Related Diseases. Life 10:4, pages 50.
Crossref
Samantha Alvarez-Herrera, Raúl Escamilla, Oscar Medina-Contreras, Ricardo Saracco, Yvonne Flores, Gabriela Hurtado-Alvarado, José Luis Maldonado-García, Enrique Becerril-Villanueva, Gilberto Pérez-Sánchez & Lenin Pavón. (2020) Immunoendocrine Peripheral Effects Induced by Atypical Antipsychotics. Frontiers in Endocrinology 11.
Crossref
Ekaterini Tiligada & Madeleine Ennis. (2018) Histamine pharmacology: from Sir Henry Dale to the 21st century. British Journal of Pharmacology 177:3, pages 469-489.
Crossref
Jean A. Boutin & Céline Legros. (2019) The five dimensions of receptor pharmacology exemplified by melatonin receptors: An opinion. Pharmacology Research & Perspectives 8:1.
Crossref
Céline Legros, Clémence Dupré, Chantal Brasseur, Anne Bonnaud, Olivier Bruno, Damien Valour, Preety Shabajee, Adeline Giganti, Olivier Nosjean, Terrence P. Kenakin & Jean A. Boutin. (2019) Characterization of the various functional pathways elicited by synthetic agonists or antagonists at the melatonin MT 1 and MT 2 receptors . Pharmacology Research & Perspectives 8:1.
Crossref
Ying Zhou, Peter J. Little, Hang T. Ta, Suowen Xu & Danielle Kamato. (2019) Lysophosphatidic acid and its receptors: pharmacology and therapeutic potential in atherosclerosis and vascular disease. Pharmacology & Therapeutics 204, pages 107404.
Crossref
Marthe Koussémou & Karl-Norbert Klotz. (2019) Agonists activate different A2B adenosine receptor signaling pathways in MBA-MD-231 breast cancer cells with distinct potencies. Naunyn-Schmiedeberg's Archives of Pharmacology 392:12, pages 1515-1521.
Crossref
Hryhorowicz, Kaczmarek-Ryś, Andrzejewska, Staszak, Hryhorowicz, Korcz & Słomski. (2019) Allosteric Modulation of Cannabinoid Receptor 1—Current Challenges and Future Opportunities. International Journal of Molecular Sciences 20:23, pages 5874.
Crossref
Simon R. Foster, Alexander S. Hauser, Line Vedel, Ryan T. Strachan, Xi-Ping Huang, Ariana C. Gavin, Sushrut D. Shah, Ajay P. Nayak, Linda M. Haugaard-Kedström, Raymond B. Penn, Bryan L. Roth, Hans Bräuner-Osborne & David E. Gloriam. (2019) Discovery of Human Signaling Systems: Pairing Peptides to G Protein-Coupled Receptors. Cell 179:4, pages 895-908.e21.
Crossref
Besma Benredjem, Jonathan Gallion, Dennis Pelletier, Paul Dallaire, Johanie Charbonneau, Darren Cawkill, Karim Nagi, Mark Gosink, Viktoryia Lukasheva, Stephen Jenkinson, Yong Ren, Christopher Somps, Brigitte Murat, Emma Van Der Westhuizen, Christian Le Gouill, Olivier Lichtarge, Anne Schmidt, Michel Bouvier & Graciela Pineyro. (2019) Exploring use of unsupervised clustering to associate signaling profiles of GPCR ligands to clinical response. Nature Communications 10:1.
Crossref
Blaine A. Jacobs, Miryam M. Pando, Elaine M. Jennings, Raehannah J. Jamshidi, Joshua C. Zamora, Teresa S. Chavera, William P. Clarke & Kelly A. Berg. (2019) Signaling characteristics and functional regulation of delta opioid-kappa opioid receptor (DOP-KOP) heteromers in peripheral sensory neurons. Neuropharmacology 151, pages 208-218.
Crossref
Marcel Bermudez, Trung Ngoc Nguyen, Christian Omieczynski & Gerhard Wolber. (2019) Strategies for the discovery of biased GPCR ligands. Drug Discovery Today 24:4, pages 1031-1037.
Crossref
Carsten Alexander Raabe, Jieny Gröper & Ursula Rescher. (2019) Biased perspectives on formyl peptide receptors. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1866:2, pages 305-316.
Crossref
Aidan J. Hampson & Robert L. Walsh. 2019. Cannabis Use Disorders. Cannabis Use Disorders 55 62 .
Daniela Volpato & Ulrike Holzgrabe. (2018) Designing Hybrids Targeting the Cholinergic System by Modulating the Muscarinic and Nicotinic Receptors: A Concept to Treat Alzheimer’s Disease. Molecules 23:12, pages 3230.
Crossref
Yoon Namkung, Christian LeGouill, Sahil KumarYubo CaoLarissa B. TeixeiraViktoriya Lukasheva, Jenna GiubilaroSarah C. SimõesJean-Michel Longpré, Dominic Devost, Terence E. HébertGraciela PiñeyroRichard LeducClaudio M. Costa-Neto, Michel Bouvier & Stéphane A. Laporte. (2018) Functional selectivity profiling of the angiotensin II type 1 receptor using pathway-wide BRET signaling sensors. Science Signaling 11:559.
Crossref
Adrian P. Campbell & Alan V. Smrcka. (2018) Targeting G protein-coupled receptor signalling by blocking G proteins. Nature Reviews Drug Discovery 17:11, pages 789-803.
Crossref
Kelly A Berg & William P Clarke. (2018) Making Sense of Pharmacology: Inverse Agonism and Functional Selectivity. International Journal of Neuropsychopharmacology 21:10, pages 962-977.
Crossref
David Perrey, Dehui Zhang, Thuy Nguyen, F. Ivy Carroll, Mei-Chuan Ko & Yanan Zhang. (2018) Synthesis of Enantiopure PZM21: A Biased Agonist of the Mu-Opioid Receptor. European Journal of Organic Chemistry 2018:29, pages 4006-4012.
Crossref
Terry Kenakin & Ryan T. Strachan. (2018) PAM-Antagonists: A Better Way to Block Pathological Receptor Signaling?. Trends in Pharmacological Sciences 39:8, pages 748-765.
Crossref
Sarah Beggiato, Andrea C. Borelli, Maria C. Tomasini, M. Paola Castelli, Nicholas Pintori, Roberto Cacciaglia, Antonella Loche & Luca Ferraro. (2018) In Vitro Functional Characterization of GET73 as Possible Negative Allosteric Modulator of Metabotropic Glutamate Receptor 5. Frontiers in Pharmacology 9.
Crossref
Antonio R. Artalejo & Luis Alcides Olivos-Oré. (2017) Alpha2-adrenoceptors in adrenomedullary chromaffin cells: functional role and pathophysiological implications. Pflügers Archiv - European Journal of Physiology 470:1, pages 61-66.
Crossref
Katia Varani, Fabrizio Vincenzi, Matteo Cadossi, Stefania Setti, Pier Andrea Borea & Ruggero Cadossi. 2018. The Adenosine Receptors. The Adenosine Receptors 557 580 .
Cyril Goudet, Xavier Rovira, Philippe Rondard, Jean-Philippe Pin, Amadeu Llebaria & Francine Acher. 2019. Structure and Function of GPCRs. Structure and Function of GPCRs 253 284 .
Simon R. Foster & Hans Bräuner-Osborne. 2018. Targeting Trafficking in Drug Development. Targeting Trafficking in Drug Development 41 61 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.